Craig Barratt, Ph.D., Chair
Craig Barratt, Ph.D. joined the Calysta Board of Directors in 2013 and was named Board Chair in 2019. He is CEO of Barefoot Networks, a developer of ultra fast networking equipment. Prior to joining Barefoot, he was VP of Access and Energy at Google. He was previously the president of Qualcomm Atheros, the network and connectivity subsidiary of Qualcomm (NASDAQ:QCOM).
Dr. Barratt joined Qualcomm in 2011 following its acquisition of Atheros Communications, a fabless semiconductor company. From 2003, he was president, CEO and a director of Atheros. He led the company through its 2004 IPO and growth to over $900 million in revenue in 2010.
Dr. Barratt previously served as Atheros’ vice president of technology from 2002 until 2003. Prior to joining Atheros, he held the role of executive vice president and general manager of ArrayComm, a company specializing in multi-antenna signal processing. He also serves on the Board of Directors at Intuitive Surgical (NASDAQ: ISRG), a pioneer in robotic assisted surgery.
Dr. Barratt holds Ph.D. and Master of Science degrees in electrical engineering from Stanford University, as well as a Bachelor of Engineering degree in electrical engineering and a Bachelor of Science degree from the University of Sydney in Australia. Dr. Barratt has been granted over 30 patents in a variety of wireless and related technologies and has co-authored a book on linear controller design, various technical publications and open source software.
David Hayes joined the Calysta Board of Directors in 2019. He is Senior Principal, BP Ventures, and brings 16 years’ experience in finance, including seven years in venture capital investing, specializing in transaction structuring. He is a Fellow of the Association of Certified Chartered Accountants (FCCA). He sits on the boards of Chromatin, Lightning Systems, Xpansiv Data Systems, and Mendel Biotechnology.
Alan Shaw, Ph.D., President, CEO and Co-Founder
Alan Shaw, Ph.D., is President, Chief Executive Officer and Co-Founder of Calysta, and a member of the Board of Directors. He joined in 2012. Dr. Shaw is a veteran biotechnology entrepreneur and chemical industry executive, with more than 25 years experience building and leading technology companies. Before joining Calysta, he was a Founder of Codexis, and served for ten years as President, Chief Executive Officer and a director. Codexis is a developer of cost-advantaged processes for production of biobased chemicals and pharmaceuticals. During his tenure, Codexis completed an IPO and expanded from a startup to a global industrial biotechnology company with operations in the United States, Europe and Asia.
In 2010, Dr. Shaw received the Ernst and Young Entrepreneur® of the Year Award in the life sciences category for Northern California. He is a member of the Board of Directors of BIO and the Governing Board of the BIO Industrial and Environmental Section. He also serves as a biotechnology advisor to the governments of the United Kingdom and Malaysia, and is a frequent speaker at leading business and industry conferences.
Prior to Codexis, Dr. Shaw held senior operating and business development positions in the United Kingdom for Chiroscience Group plc and for the chemical and biopharmaceutical units of Clariant and BTP plc from 1994-99. For the previous 15 years, he held management and scientific leadership positions for Imperial Chemical Industries plc (ICI)/Zeneca, including Business Head, Fine Chemicals and Marketing Manager, European Sales. He holds a bachelor’s degree in chemistry from Teesside University and a Ph.D. in chemistry from the University of Durham, England. He is a Fellow of the Royal Society of Chemistry and a Fellow of the Chartered Institute of Marketing.
Suan Swee Tan
Suan Swee Tan joined the Calysta Board of Directors in 2017. He is Managing Director, Investments of Temasek International, overseeing the agribusiness and biosciences sectors. At Temasek, Mr Tan has been involved in investment deals in agribusiness, life sciences and energy.
He is presently on the board of the Pavilion Energy group, which is importing and trading in natural gas; Cargill Tropical Palm, a joint venture with Cargill; and Jilin Food Zone which is developing an industrial park in China. Outside Singapore, Mr. Tan is on the board of Ceva Sante, an animal health products company based in France. Mr Tan is also on the board of Temasek Life Sciences Laboratory, an R&D institute focusing on research in plant and animal sciences.
Prior to joining Temasek in 2003, Mr Tan was Assistant Managing Director of Singapore’s Economic Development Board (EDB). In his 16 years at EDB, he headed the energy and chemical industry clusters, and biomedical sciences. He also led the board’s European Operations. He was a principal player in the development of Jurong Island as a hub for the chemical industry.
Mr Tan holds a Bachelor’s Degree in Chemical Engineering from the University of Adelaide, South Australia on a Colombo Plan Scholarship and an MBA from the National University of Singapore.
Rich Torres joined the Calysta Board of Directors in 2019. Mr. Torres currently serves as Vice President and Global Trading Director for Cargill’s Grain Milling Businesses, Starches, Sweeteners and Texturizers.
In this role, Mr. Torres is responsible for all commodity risk associated with grains, biofuel, proteins, corn oil, fibers and various other commodities found in Cargill’s Grain Processing Business. He has 30 years of leadership experience in Cargill, focusing on risk and product line management, trading and commodity merchandising.
Before taking on his current role, Mr. Torres managed Cargill’s North American Corn Milling Trading and Merchandising function, oversaw Cargill’s NA corn oil business, and served on a variety of business leadership teams, including as a member of ProGold, LLC oversight board and as a director of Agri-Grain Marketing. Mr. Torres began his Cargill career in 1989 as a Dayton, Ohio-based commodity trader.
Mr. Torres holds a Bachelor of Science degree in Agricultural and Managerial Economics from the University of California, Davis. Throughout his career, Mr. Torres has served on numerous community boards and various industry associations.
Mike Velings joined the Calysta Board of Directors and the Advisory Board in 2015. He is the founder and the driving force behind Aqua-Spark, a global investment fund for sustainable aquaculture, combining a healthy financial profit with environmental and social impact. A lifelong entrepreneur, Mike has spent decades jumpstarting a range of successful businesses. Among other ventures, he co-founded Connexie, which has helped catalyze a professional employment industry across the Netherlands. Mike naturally combines his business background with environmental and social engagement. He understands the potential for business to create durable solutions to complex world problems. With this in mind, Mike founded A-Spark: an investment company that assists entrepreneurs across the globe in realizing their visions of a start-up with a world-changing element. Through A-Spark he has invested in a broad range of ventures over the years– both in the developed and developing world. Mike serves on several boards and is also a member of the Chairman’s Council of Conservation International and an Honorary Global Marine Fellow.